Depression as a risk factor for cardiovascular disease

Primary Psychiatry

Volumn 12, Issue 5, 2005, Pages 36-41

  Stewart, Thomas ^a,b   Yusim, Anna ^a   Desan, Paul ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; CLOPIDOGREL; NITRIC OXIDE; PAROXETINE; PLACEBO; SERTRALINE; THROMBOCYTE FACTOR 4;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; HEALTH BEHAVIOR; HEALTH SURVEY; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; INCIDENCE; MAJOR DEPRESSION; MELANCHOLIA; PHYSICIAN; PREVALENCE; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; THROMBOCYTE FUNCTION; UNSTABLE ANGINA PECTORIS; VASODILATATION;

EID: 19644384515     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Myers JK, Weissman MM, Tischler CL, et al. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry. 1984;41(10):959-967.
2. Katon W, Schulberg H. Epidemiology of depression in primary care, Gen Hasp Psychiatry. 1992;14(4):237-247.
3. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989;149(8):1785-1789.
4. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1980.
5. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50(6):627-633.
6. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270(15):1819-1825.
7. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998;155(1):4-11.
8. Lesperance F, Erasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med, 2000;160(9):1354-1360.
9. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
10. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP, Relation between depression after coronary artery bypass surgery and 12-month outcome; a prospective study. Lancet. 2001;358(9295):1766-1771.
11. Malzberg B. Mortality Among Patients with Mental Disease. Albany, NY: Department of Mental Hygiene; 1934.
12. Malzberg B. Mortality among patients with involution melancholia. Am J Psychiatry. 1937;93(5):1231-1238.
13. Dreyfuss F, Dasberg H, Assael, MI. The relationship of myocardial infarction to depressive illness. Psychother Psychosom. 1969;17(2):73-81.
14. Wecke A, Juel K, Vaeth M. Cardiovascular death and manic-depressive psychosis. J Affect Disord. 1987;13(3):287-292.
15. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 1993;4(4):285-294.
16. Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary arteiy disease in men; the precursors study. Arch Intern Med. 1998;158(13):1422-1426.
17. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003;65(2):201-210.
18. Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med. 2002;23(1):51-61.
19. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction, Circulation. 1995;91(4):999-1005.
20. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987.
21. Lesperance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049-1053.
22. Carney RM, Blumenthal JA, Catellier D, et al. Depression as a risk factor for mortality after acute myocardial infarcation, Am J Cardiol. 2003;92(11):1277-1281.
23. Carney RM, Freedland KE, Jaffe AS, et al. Depression as a risk factor for post-MI mortality. J Am Coll Cardiol. 2004;44(2):472.
24. Lane D, Carroll D, Ring C, et al. Mortality and quality of life 12 months after myocardial infarction; effects of depression and anxiety. Psychosom Med. 2001;63(2):221-230.
25. Lane D, Carroll D, Lip GY, Anxiety, depression, and prognosis after myocardial infarction; is there a causal association? J Am Coll Cardiol. 2003;42(10):1808-1810.
26. Finkel MS. Molecular signaling pathways that link depression and heart disease. In: Ford DE, Finkel MS, Culpepper L, eds. Managing Depression in Patients with Cardiovascular Disease (Postgraduate Medicine: A Special Report). Minneapolis, MN: McGraw-Hill Healthcare Information Group; 2003:14-27.
27. Ignarro LJ. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview, J Physiol Pharmacol. 2002;33(4):503-514.
28. Node K, Kitakaze M, Yoshikawa H, et al. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension. 1997;30(3):405-408.
29. NodeK, Kitakaze M, Yoshikawa H, et al, Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol. 1997;79(11):1538-1541.
30. Chrapko WE, Jurasz P, Radomskl MW, et al. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry. 2004;56(2):129-134.
31. Rajagopalan S, Brook R, Rubenfire M, et al. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol. 2001;88(2):196-198.
32. Smitherman TC, Milam M, Woo J, et al, Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo, Am J Cardiol. 1981;48(3):395-402.
33. Levine SP, Lindenfeld J, Ellis JB, et al. Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion, Circulation. 1981;64(3):626-632.
34. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153(10):1313-1317.
35. 5, Lederbogen F, Gilles M, Maras A, et al. Increased platelet aggregability in major depression? Psychiatry Res. 2001;102(3):255-261.
36. Maes M, Van der Planken M, Van Gastel A, et al. Blood coagulation and platelet aggregation in major depression, J Affect Disord. 1996;40(1-2):35-40.
37. von Kanel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand. 2004;110(3):163-177.
38. Laghrissi-Thode F, Wagner WR, Pollock BG, et al, Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997;42(4):290-295.
39. Kuijpers PM, Hamulyak K, Strik JJ, et al. Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression, Psychiatry Res. 2002;109(2):207-210.
40. Serebruany VL, Glassman AH, Malinin AI, et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from .recent clinical trials. Blood Coagul Fibrinolysis. 2003;14(6):563-567.
41. Goldberger AL. Is the normal heartbeat chaotic or homeostatic? News Physiol Sci. 1991;6:87-91.
42. Havlin S, Buldyrev SV, Bunde A, et al. Scaling in nature: from DNA through heartbeats to weather. Physica A. 1999;273(1-2):46-69.
43. Goldberger AL, Peng CK, Lipsitz LA. What is physiologic complexity and how does it change with aging and disease? Neurobiol Aging. 2002;23(1):23-26.
44. Bigger JT Jr, Fleiss JL, Steinman RC, et al, Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85(1):164-171.
45. Camey RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS, Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 1995;76(8):562-564.
46. Carney RM, Blumenthal JA, Stein PK, et al, Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104(17):2024- 2028.
47. Agelink MW, Boz C, Ullrich H, et al. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res. 2002;113(1-2):139-149.
48. Lara N, Archer SL, Baker GB, et al. Paroxetine-induced increase in metabolic end products of nitric oxide. J din Psychopharmacol. 2003;23(6):641-645.
49. Serebruany VL, Glassman AH, Malinin AI, et al, for the Sertraline Antidepressant Heart Attack Randomized Trial Study Group. Platelet/ endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation. 2003;108(8):939-944.
50. Diagnostic and Statistical Manual of Mental Disorders. 4th ed text rev. Washington, DC: American Psychiatric Association: 2000.
51. McFarlane A, Kamath MV, Fallen EL, et al. Effect of sertraline on the recovery rate of cardiac autonomie function in depressed patients after acute myocardial infarction. Am Heart J. 2001:142(4):617-623.
52. Carney RM, Freedland KE, Stein PK, et al. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med. 2000;62(5):639-647.
53. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108(1):32-36.
54. Glassman AH, O'Connor CM, Califf RM, et al, for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina, JAMA. 2002;288(6):701-709.
55. Swenson JR, O'Connor CM, Barton D, et al, for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol. 2003:92(11): 1271-1276.
56. Frasure-Smith N, Lesperance F, Gravel G, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101(16):1919-1924.
57. Ruberman W, Weinblatt E, Goldberg JD, et al. Psychosocial influences on mortality after myocardial infarction. N Engl J Med. 1984;311(8):552-559.
58. Berkman LF, Blumenthal J, Burg M, et al, for the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Group. Effects of treating depression and low perceived social support on clinical events after myocardial infarction; the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003:289(23):3106-3116.